Assessment of Physical Functioning and Handling of Spiolto Respimat in Patients With Chronic Obstructive Pulmonary Disease (COPD) Requiring Long-acting Dual Bronchodilation in Routine Clinical Practice
Latest Information Update: 01 Oct 2019
At a glance
- Drugs Olodaterol/tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 29 Oct 2018 Status changed from active, no longer recruiting to completed.
- 25 Sep 2018 Status changed from recruiting to active, no longer recruiting.
- 20 Apr 2018 Planned End Date changed from 15 Jun 2018 to 26 Oct 2018.